Stealth BioTherapeutics Corp. - ADS (MITO) News

Stealth BioTherapeutics Corp. - ADS (MITO): $0.32

0.00 (-1.36%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add MITO to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#180 of NR

in industry

Filter MITO News Items

MITO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MITO News Highlights

  • For MITO, its 30 day story count is now at 1.
  • list("500 - Internal server error")
  • CARR are the most mentioned tickers in articles about MITO.

Latest MITO News From Around the Web

Below are the latest news stories about Stealth BioTherapeutics Corp that investors may wish to consider to help them evaluate MITO as an investment opportunity.

Stealth BioTherapeutics Corp (MITO) CEO Reenie McCarthy on Q4 2020 Results - Earnings Call Transcript

Stealth BioTherapeutics Corp (MITO) Q4 2020 Results Earnings Conference Call April 06, 2021, 08:30 AM ET Company Participants Henry Hess - Chief Legal Counsel Reenie McCarthy - Chief Executive Officer Jim Carr - Chief Clinical Development Officer Rob Weiskopf - Chief Financial Officer Brian Blakey - Chief Business Officer Conference...

SA Transcripts on Seeking Alpha | April 6, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!